Comment Letter
Comment Letter on FDA's "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products"
Valerie J. Parker, Rachele Hendricks-Sturrup
2026
Read MoreOp-Ed
Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Scott Gottlieb and Mark B. McClellan
STAT, 2026
Read MoreWhite Paper
A Vision for Modernizing Medicare Risk Adjustment: Building the Evidence for Reform
Audrey Ford, Sara Debab, Inga Morken, Frank McStay, Boris Vabson, Mark McClellan
2026
Read MoreComment Letter
Comment Letter on CMS IPAY 2029 Proposed Rule
Nitzan Arad, Rachele Hendricks-Sturrup, Mark McClellan
2026
Read More